EMD 5.26% 5.4¢ emyria limited

I think their early focus on MDMA compared to psilocybin is...

  1. 37 Posts.
    lightbulb Created with Sketch. 23
    I think their early focus on MDMA compared to psilocybin is strategic - there is better high quality data at this stage which is favourable when put to ethics committees. I think more likely to find TGA approval as well - there’s no guarantee come December that the TGA will down schedule both (if any).
    Last edited by kanyekrush: 11/10/21
 
watchlist Created with Sketch. Add EMD (ASX) to my watchlist
(20min delay)
Last
5.4¢
Change
-0.003(5.26%)
Mkt cap ! $22.08M
Open High Low Value Volume
5.7¢ 5.7¢ 5.4¢ $2.373K 42.51K

Buyers (Bids)

No. Vol. Price($)
1 100000 5.3¢
 

Sellers (Offers)

Price($) Vol. No.
5.5¢ 92984 1
View Market Depth
Last trade - 15.55pm 09/07/2024 (20 minute delay) ?
EMD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.